Werewolf Therapeutics (HOWL) Non-Current Assets (2020 - 2026)

Werewolf Therapeutics (HOWL) has reported Non-Current Assets for 7 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 89.59% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $32.8 million, a 38.05% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 22.02% from the prior year.
• Non-Current Assets was $1.3 million for Q2 2026 at Werewolf Therapeutics, down from $9.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $38.5 million in Q1 2023 and troughed at $1.3 million in Q2 2026.
• A 5-year average of $20.4 million and a median of $17.1 million in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 424.73% in 2022 and slumped 89.59% in 2026, its largest moves.
• Over 5 years, Non-Current Assets stood at $20.0 million in 2022, then jumped by 81.91% to $36.5 million in 2023, then slumped by 61.98% to $13.9 million in 2024, then declined by 22.02% to $10.8 million in 2025, then sank by 88.32% to $1.3 million in 2026.
• The last three Non-Current Assets figures came in at $1.3 million (Q2 2026), $9.3 million (Q1 2026), and $10.8 million (Q4 2025), per Business Quant data.